Proteomics and metabolomics are two emerging fields that hold promise to shine light on the
molecular mechanisms causing neurodegenerative diseases. Research in this area may …

Abstract Background Reliable biomarkers for Parkinson's disease (PD) diagnosis are
urgently needed. Alpha-synuclein (α-syn) and its proteoforms play a key role in PD …

Parkinson's disease (PD) is the most common neurodegenerative disorder with motor
symptoms. The neuropathological alterations characterizing the brain of patients with PD …

The formation of soluble α-synuclein (α-syn) and amyloid-β (Aβ) aggregates is associated
with the development of Parkinson's disease (PD). Current methods mainly focus on the …

Background Whole-body electromyostimulation (WB-EMS) was never previously applied to
Parkinson's disease (PD) patients. This randomized controlled study aimed to find the most …

The search for a reliable, early-disease biomarker for Parkinson's disease (PD) that reflects
underlying pathology is a high priority in PD research. Salivary alpha-synuclein (α-Syn) is an …

Human red blood cells (RBCs) are unique cells with the remarkable ability to deform, which
is crucial for their oxygen transport function, and which can be significantly altered under …

Finding reliable biomarkers has a crucial role in Parkinson's disease (PD) assessments.
Saliva is a bodily fluid, which might be used as a source of biomarkers for PD. Our article …

Objective In this study, we assessed plasma biomarkers to identify cognitive impairment in
Parkinson's disease (PD) patients by applying ultra-sensitive immunomagnetic reduction …

Abstract After Alzheimer's disease, Parkinson's disease is the most frequent
neurodegenerative disorder. Although numerous treatments have been developed to control …